Overview * PHINIA ( PHIN ) Q3 net sales rise 8.2% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats analyst estimates * Company completes $47 mln acquisition of SEM, enhancing alternative fuel systems Outlook * Company expects 2025 net sales between $3.39 bln and $3.45 bln * PHINIA ( PHIN ) projects 2025 net earnings of $100 mln...

Overview * Repligen ( RGEN ) Q3 revenue grows 22% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * Company raises full-year revenue guidance to $729-$737 mln, indicating confidence in growth Outlook * Repligen ( RGEN ) raises full-year revenue guidance to $729 mln - $737 mln * Company expects full-year adjusted EPS...

Overview * Kiniksa Q3 2025 ARCALYST revenue grows 61% yr/yr to $180.9 mln * Company raises 2025 ARCALYST revenue guidance to $670-$675 mln * KPL-387 granted Orphan Drug Designation for pericarditis treatment Outlook * Kiniksa raises 2025 ARCALYST revenue guidance to $670 mln - $675 mln * Company expects to remain cash flow positive annually * Data from KPL-387 Phase...

07:40 AM EDT, 10/28/2025 (MT Newswires) -- LSL Pharma Group (LSL.V) said Tuesday that Health Canada has approved its first six sterile ophthalmic solutions for the treatment of glaucoma and allergies. The commercial launch of these products is expected to begin in the second quarter of next year. This approval strengthens LSL Pharma's presence in the sterile ophthalmic pharmaceuticals sector....